Bryn Pharma

Beverly Hills, United States

Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis.

$26.7M raised

May 2023

Venture - Series Unknown

Top Investors

Capstone PartnersRezVen PartnersAllerFundChazen Capital Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Bryn Pharma raised?

Bryn Pharma has raised $26.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.

Who are Bryn Pharma's investors?

Bryn Pharma's investors include Capstone Partners, RezVen Partners, AllerFund, Chazen Capital Partners.

Where is Bryn Pharma headquartered?

Bryn Pharma is headquartered in Beverly Hills, United States.

What does Bryn Pharma do?

Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis.

What stage is Bryn Pharma at?

Bryn Pharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 10, 2023.

MLA

"Bryn Pharma — Funding & Investors." VCBacked, May 10, 2023, https://www.vcbacked.co/company/bryn-pharma. Accessed June 15, 2026.

APA

VCBacked. (2023). Bryn Pharma — Funding & Investors. Retrieved June 15, 2026, from https://www.vcbacked.co/company/bryn-pharma

Wikipedia (cite web)

{{cite web |title=Bryn Pharma — Funding & Investors |url=https://www.vcbacked.co/company/bryn-pharma |website=VCBacked |access-date=June 15, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 10, 2023.